In this webinar, Dora Barna, Chemaxon’s Principal Application Scientist presented how a hypothesis and synthesis management platform facilitates data-driven decision-making and increases the efficiency of drug discovery project execution.
There have been some comparative studies done by independent researchers and evaluators wherein they have compared the Molsoft’s ICM with other molecular modeling tools in the market. Read on to know how ICM has outperformed others.
We could finally host the much-awaited Chemaxon UGM in India in November, 2022, which was attended by 30 well-known dignitaries from well-known CROs, pharma, and chemical companies. We are grateful to all the participants for attending the event.
Introducing our new logo. We not only want to understand our customer’s pain areas but also want to become a one-stop destination for their solutions. Hence, our new logo represents joining hands and offering the best solution from our global partners.
Molsoft and Advent Informatics signed an agreement to promote distribution of Molsoft products in India utilizing the marketing and research Experience of Advent Informatics.
